Risk factors for mortality of medical causes within 30 days of electroconvulsive therapy
2023 (English)In: Journal of Affective Disorders, ISSN 0165-0327, E-ISSN 1573-2517, Vol. 320, p. 527-533Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Electroconvulsive therapy (ECT) is used to treat severe psychiatric disorders and is associated with reduced risk of suicide and all-cause mortality in patients with severe depression. We investigated the causes of death occurring shortly after ECT and identified potential risk factors for medical causes of death.
METHODS: Patients treated with ECT between 2012 and 2018 were included in this Swedish register-based study. Multivariate binary logistic regression was used to calculate odds ratios for covariates to determine potential predictors of 30-day mortality.
RESULTS: Of the 20,225 included patients, 93 (0.46 %) died of suicide and 123 (0.61 %) died of medical causes after ECT. Cardiovascular disease was the most common medical cause of death (n = 49, 40 %). An older age, a Charlson Comorbidity Index of 1 or more, atrial fibrillation, kidney disease, reflux disease, dementia, and cancer were associated with increased risk of death by medical causes.
LIMITATIONS: Real-life observational studies based on registry data may demonstrate associations, but cannot determine causality. If medical records had been available, we would be better able to determine if deaths were due to the ECT, anesthesia, pre-existing medical conditions, or the mental disorder.
CONCLUSIONS: ECT appears to be a low-risk medical procedure. Older individuals with severe somatic diseases have the highest risk of death and extra measures should be considered to optimize their medical health during the pre-ECT workup, and during and after ECT.
Place, publisher, year, edition, pages
Elsevier, 2023. Vol. 320, p. 527-533
Keywords [en]
Death, Electroconvulsive therapy, Medical risk factors
National Category
Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-101748DOI: 10.1016/j.jad.2022.10.008ISI: 000888135400002PubMedID: 36209782Scopus ID: 2-s2.0-85139728107OAI: oai:DiVA.org:oru-101748DiVA, id: diva2:1702946
2022-10-122022-10-122022-12-13Bibliographically approved